Royal Bank of Canada
TNGX icon

Royal Bank of Canada’s Tango Therapeutics TNGX Stock Holding History

Royal Bank of Canada’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7K Sell
350
-3,332
-90% -$46.4K ﹤0.01% 6339
2025
Q4 		$32K Sell
3,682
-283,817
-99% -$2.45M ﹤0.01% 5802
2025
Q3 		$2.42M Buy
287,499
+35,226
+14% +$238K ﹤0.01% 3239
2025
Q2 		$1.29M Buy
252,273
+250,852
+17,653% +$620K ﹤0.01% 3673
2025
Q1 		$2K Sell
1,421
-513
-27% -$1.26K ﹤0.01% 6596
2024
Q4 		$6K Sell
1,934
-4,866
-72% -$22.6K ﹤0.01% 6505
2024
Q3 		$53K Sell
6,800
-169
-2% -$1.61K ﹤0.01% 5670
2024
Q2 		$59K Buy
6,969
+4,440
+176% +$34.3K ﹤0.01% 5570
2024
Q1 		$20K Sell
2,529
-11,216
-82% -$120K ﹤0.01% 5927
2023
Q4 		$136K Buy
13,745
+6,236
+83% +$54.1K ﹤0.01% 5411
2023
Q3 		$84K Buy
7,509
+2,847
+61% +$17.4K ﹤0.01% 5501
2023
Q2 		$15K Buy
4,662
+2,036
+78% +$7.32K ﹤0.01% 6337
2023
Q1 		$10K Sell
2,626
-4,037
-61% -$23.4K ﹤0.01% 6335
2022
Q4 		$48K Buy
6,663
+6,096
+1,075% +$42.9K ﹤0.01% 5911
2022
Q3 		$2K Buy
567
+305
+116% +$1.3K ﹤0.01% 7068
2022
Q2 		$1K Sell
262
-3,919
-94% -$23.7K ﹤0.01% 7207
2022
Q1 		$32K Buy
+4,181
New +$36.2K ﹤0.01% 6354

Other funds holding TNGX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Royal Bank of Canada's TNGX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Tango Therapeutics (TNGX) stake by 90% in Q1 2026, selling an estimated $46.4K and leaving 350 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #6339.

Royal Bank of Canada first reported a position in TNGX in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.42M in Q3 2025. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.

  • Royal Bank of Canada held 350 shares of Tango Therapeutics worth $7K as of Q1 2026.
  • Royal Bank of Canada sold 3,332 Tango Therapeutics shares in Q1 2026, an estimated $46.4K.
  • Tango Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6339 holding.
  • Royal Bank of Canada first reported a position in Tango Therapeutics in Q1 2022 and has held it in 17 quarters since.
  • Royal Bank of Canada's Tango Therapeutics position peaked at $2.42M in Q3 2025.
  • 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.